United States· US:0178-0500_47e7b4dd-b3b1-f6a0-e063-6294a90a1bca
Lithostat
A acetohydroxamic acid product containing acetohydroxamic acid, registered in United States by Mission Pharmacal Company. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Acetohydroxamic acid is registered in 2 of 19 countries.
Countries holding a registration under ATC G04BX03 (acetohydroxamic acid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Acetohydroxamic acid · ATC G04BX03
2 / 19 countries
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ACETOHYDROXAMIC ACID
- Manufacturer
- Mission Pharmacal Company
- Country
- United States (US)
- ATC code
- G04BX03
- ATC class
- Acetohydroxamic acid
- Defined daily dose
- 0.75 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110178050001100 TABLET in 1 BOTTLE (0178-0500-01)
- ndc110178-0500-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
9 interactions on record for acetohydroxamic acid.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acetohydroxamic acid · interactions on record
9 records
- 2 severe
- 7 moderate
Most severe, free to view
- CladribineL01BB04severe
- CladribineL04AA40severe
- AlemtuzumabL01XC04moderate
- Omacetaxine mepesuccinateL01XX40moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Acetohydroxamic acid in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainURONEFREX 125 mg CAPSULASFerrer Internacional S.A.
- United KingdomAcetohydroxamic acid 250mg capsulesSpecial Order
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Spain · Uronefrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/233c2c81-f593-4b2c-ae2f-26269bda6a34 GET /v1/drugs/233c2c81-f593-4b2c-ae2f-26269bda6a34?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250",
"substance": "ACETOHYDROXAMIC ACID",
"productndc": "0178-0500",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA018749",
"marketing_category": "NDA"
}See everything about acetohydroxamic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.